Rc. Barnard, EXECUTIVE-ORDER-12866 - ADVANTAGES AND DISADVANTAGES OF THE ADMINISTRATIONS NEW REGULATORY PLAN ON RISK, BENEFIT, AND COSTS, Regulatory toxicology and pharmacology, 23(3), 1996, pp. 178-182
The 1993 Executive Order 12866 as implemented by the 1996 OMB document
proposes a new paradigm for the evaluation of risks, benefits, and co
sts. The new regulatory plan would replace the current methodology in
two ways. In place of the current methodology for risk. assessment bas
ed on conservative generic default assumptions that provide an upper-b
ound risk value that is treated as the ''benefit,'' the new regulatory
plan establishes a state of the art guidance for the economic evaluat
ion of risks, benefits, and costs. Second, the new plan requires chang
es in risk assessment to provide the necessary foundation for the new
economic evaluation of risks, benefits, and costs. The advantages and
disadvantages of the new regulatory plan are discussed. (C) 1996 Acade
mic Press, Inc.